We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIR
14426
PUT
DELISTED
CIRCOR International, Inc
CIR
-8,600
Closed -$229K
EMAN
14427
DELISTED
eMagin Corporation
EMAN
-58,355
Closed -$66K
CCV.WS
14428
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
-220,036
Closed -$134K
ELYS
14429
PUT
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
-14,900
Closed -$35K
ZYNE
14430
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-41,665
Closed -$53.1K
JUN
14431
DELISTED
Juniper II Corp.
JUN
-950,366
Closed -$9.46M
BIOS
14432
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
-88,240
Closed -$871K
BIOSW
14433
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
-375,000
Closed -$83K
FZT.WS
14434
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
-249,999
Closed -$83K
CGRN
14435
CALL
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-12,300
Closed -$51K
VQS
14436
PUT
DELISTED
VIQ SOLUTIONS INC
VQS
-40,000
Closed -$65K
LMNL
14437
CALL
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
-3,240
Closed -$33K
MMP
14438
DELISTED
Magellan Midstream Partners, L.P.
MMP
-225,667
Closed -$11.3M
BRDS
14439
PUT
DELISTED
Bird Global, Inc.
BRDS
-924
Closed -$57K
CPTN
14440
DELISTED
Cepton, Inc. Common Stock
CPTN
-1,390
Closed -$54K
UTAA
14441
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
-450,084
Closed -$4.44M
TKAT
14442
CALL
DELISTED
Takung Art Co., Ltd.
TKAT
-34,800
Closed -$78K
HARP
14443
PUT
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-1,110
Closed -$55K
NUVA
14444
CALL
DELISTED
NuVasive, Inc.
NUVA
-10,200
Closed -$578K
CUBS
14445
DELISTED
Asian Growth Cubs ETF
CUBS
-8,805
Closed -$217K
FXLV
14446
CALL
DELISTED
F45 Training Holdings Inc.
FXLV
-18,300
Closed -$196K
FXLV
14447
PUT
DELISTED
F45 Training Holdings Inc.
FXLV
-31,800
Closed -$340K
WAVC
14448
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
-756,144
Closed -$7.32M
CLVR
14449
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
-470
Closed -$18.8K
FORG
14450
DELISTED
ForgeRock, Inc.
FORG
-14,695
Closed -$289K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.